This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. AIM Vaccine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.072. AIM Vaccine Co's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is HK$0.00.
As of today (2024-06-20), AIM Vaccine Co's share price is HK$7.12. AIM Vaccine Co's Median PS Value is HK$0.00. Therefore, AIM Vaccine Co's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for AIM Vaccine Co's Median PS Value or its related term are showing as below:
HKSE:06660's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.66 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
AIM Vaccine Co Median PS Value Historical Data
The historical data trend for AIM Vaccine Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AIM Vaccine Co's Median PS Value
For the Biotechnology subindustry, AIM Vaccine Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AIM Vaccine Co's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where AIM Vaccine Co's Price-to-Median-PS-Value falls into.
AIM Vaccine Co Median PS Value Calculation
AIM Vaccine Co's Median PS Value for today is calculated as
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.072.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIM Vaccine Co (HKSE:06660) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
AIM Vaccine Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
7.12
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIM Vaccine Co Median PS Value Related Terms
Thank you for viewing the detailed overview of AIM Vaccine Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development, manufacturing and commercialization. The products available for sale mainly include Recombinant HBV vaccine, Human rabies vaccine, HFRS Vaccine, hepatitis A vaccine (human diploid cell), Group A, C, Y and W135 MPSV, mumps vaccine, freeze-dried human rabies vaccine (Vero cell) and ACYW135 meningococcal polysaccharide vaccine. Geographically, the company generates all of its revenues in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06660 has been successfully added to your